- Yin H, Kalra L, Lai Z, Guimaro MC, Aber, L, Warner BM, Michael DG, Zhang N, Cabrera-Perez J, Karim A, Swaim B, Afione S, Voigt A, Nguyen CQ, Yu PB, Bloch DB, Chiorini JA. Inhibition of Bone Morphogenetic Protein 6 Receptors Ameliorates Sjögren’s Syndrome in Mice. Sci Rep. 2020 Feb 19;10(1):2967. PDF
- Dinter T, Bocobo GA, Yu PB. Pharmacologic Strategies for Assaying BMP Signaling Function. Methods Mol Biol. 2019 Aug;1891:221-33. PDF
- Hoeman CM, Cordero FJ, Hu G, Misuraca K, Romero MM, Cardona HJ, Nazarian J, Hashizume R, McLendon R, Yu PB, Procissi D, Gadd S, Becher OJ. ACVR1 R206H Cooperates With H3.1K27M in Promoting Diffuse Intrinsic Pontine Glioma Pathogenesis. Nature Communications. 2019 Mar 4;10(1):1023. PDF
- Mohedas AH, Xing X, Armstrong KA, Bullock AN, Cuny GD, Yu PB. Development of a Highly Selective Inhibitor of the BMP Type I Receptor Kinase ALK2. ACS Chemical Biology. 2013 Apr; 8(6): 1291-1302. PDF
- Wrighton KH, Lin X, Yu PB, Feng XH. TGF-b Can Stimulate Smad1 Phosphorylation Independently of BMP Receptors. Journal of Biological Chemistry. 2009 Apr; 284(15): 9755-63. PDF
- Bagarova J, Vonner AJ, Armstrong KA, Böergermann J, Lai CS, Deng DY, Beppu H, Alfano I, Filippakopoulos P, Morrell NW, Bullock AN, Knaus P, Mishina Y, Yu PB. Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation. Molecular and Cellular Biology. 2013 Jun; 33(12): 2413-24. PDF
- Yu PB*, Hong CC*, Sachidanandan C*, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. Dorsomorphin Inhibits BMP Signals Required for Embryogenesis and Iron Metabolism. Nat Chem Biol. 2008 Jan; 4(1): 33-41. *equal contribution. PDF
- Yu PB, Beppu H, Kawai N, Li E, Bloch KD. Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-Specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells. J Biol Chem. 2005 Jul 1;280(26):24443-50. PDF
